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Abstract 
Background 
Methicillin-resistant Staphylococcus aureus (MRSA) has of late emerged as a cause of 
community-acquired infections among immunocompetent adults without risk factors. Skin 
and soft tissue infections represent the majority of community-acquired methicillin-resistant 
Staphylococcus aureus (CA-MRSA) clinical presentations, whilst invasive and life-
threatening illness like necrotizing pneumonia, necrotizing fasciitis, pyomyositis, 
osteomyelitis and sepsis syndrome are less common. Although more widely described in the 
pediatric age group, the occurrence of CA-MRSA osteomyelitis in adults is an uncommonly 
reported entity. 
Case presentation 
We describe an invasive CA-MRSA infection in a 28 year-old previously healthy male, 
manifesting with bacteraemia, osteomyelitis of femur, pyomyositis and septic arthritis of the 
knee. Initially a preliminary diagnosis of osteosarcoma was suggested by imaging studies and 
patients underwent a bone biopsy. MRSA was subsequently isolated from blood cultures 
taken on day of admission, bone, tissue and pus cultures. Incision and drainage of abscess 
was performed and patient was treated with vancomycin, with fusidic acid added later. It took 
6 months for the inflammatory markers to normalize, warranting 6-months of anti-MRSA 
therapy. Patient was a fervent deer hunter and we speculate that he acquired this infection 
from extensive direct contact with deer. 
Molecular characterization of this isolate showed that it belonged to multilocus sequence type 
(MLST) ST30 and exhibited the staphylococcal chromosome cassette mec (SCCmec) type 
IV, staphylococcus protein A (spa) type t019, accessory gene regulator (agr) type III and dru 
type dt10m. This strain harbored Panton-Valentine leukocidin (pvl) genes together with 3 
other virulent genes; sei (enterotoxin), hlg (hemolysin) and fnbA (fibronectin binding 
protein). 
Conclusion 
This case study alerts physicians that beyond the most commonly encountered skin and soft 
tissue infections, pvl positive CA-MRSA can lead to invasive life-threatening disease 
especially in an immunocompetent adult. Heightened alertness is needed for osteomyelitis of 
long bones in adults, as it is not uncommon for this disease to mimic primary bone 
malignancy. Cure is achievable with early appropriate antibiotics guided by inflammatory 
markers. 
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Background 
Although traditionally regarded a healthcare-associated pathogen, methicillin-resistant 
Staphylococcus aureus has now emerged as an important cause of infections in the 
community, with little or no links to healthcare setting [1-3]. Community-acquired 
methicillin-resistant S. aureus strains (CA-MRSA) carry the smaller staphylococcal 
chromosome cassette mec (SCCmec) types IV or V whereas the larger SCCmec types I, II 
and III are present in MRSA conventionally associated with infections in healthcare facilities 
[1]. The virulence of CA-MRSA may in part be related to its ability to produce toxins, such 
as Panton-Valentine leukocidin (PVL) which has an unique ability to kill leukocytes [2], 
resulting in bacterial evasion of bactericidal function of leukocytes [4]. Although initially 
associated with skin infections, PVL has recently been shown to play an essential role in the 
pathogenesis of invasive infections such as necrotizing pneumonia and osteomyelitis [1,2]. 
Overall, skin and soft-tissue infections represent about 77% to 90% of CA-MRSA infections 
and these are predominantly abscesses or cellulitis [2,3]. Although reported much less 
frequently, of greater concern are reports of invasive infections with CA-MRSA manifesting 
as bacteraemia, osteomyelitis, pneumonia and septic arthritis [3,4]. Osteomyelitis alone 
accounts for only 1 % of all CA-MRSA infections [2,3] and has been widely described in the 
pediatric age group [5]. On the contrary, the occurrence of CA-MRSA osteomyelitis in adults 
is an uncommonly reported entity. Herein, we report an invasive CA-MRSA infection in a 
previously healthy male presenting with bacteraemia, osteomyelitis of femur, pyomyositis 
and septic arthritis. He is a fervent deer hunter and presumably acquired this infection from 
extensive contact with deer after a hunting venture. This strain of CA-MRSA harbored both 
SCCmec type IV and pvl genes together with 3 other virulent genes; sei (enterotoxin), hlg 
(hemolysin) and fnbA (fibronectin binding protein). We also reviewed the literature for 
previously reported cases of osteomyelitis caused by CA-MRSA in adults. 
Case presentation 
Clinical presentation, investigation and management 
A 28 year-old-man presented with progressive pain and swelling on the left thigh for 2 weeks 
prior to admission associated with intermittent fever. This pain started off as a deep boring 
pain associated with rest pain and night pain. It progressively got worst till he was unable to 
bear weight on the affected limb and was bound to a wheelchair. In addition to that, he also 
experienced constitutional symptoms such as loss of appetite and loss of weight. He denied 
history of cough, night sweats, haemoptysis or recent contact with tuberculosis patients. 
There were no recent skin or soft tissue lesions in him or any of his household contacts. No 
exposure to healthcare settings or any hospital interventions were elicited within the past one 
year. There was no previous medical history and he had not received antibiotic treatment in 
the past 3 months. 
Our patient is a civil servant who worked temporarily in Sabah, a state in East Malaysia. He 
is an avid deer hunter and 2 weeks prior to his clinical presentation he went deer hunting with 
a hunting partner and caught 3 deer from a forest in Tawau, a small town located at the south-
east coast of Sabah. There was extensive direct contact with the deer carcass as he 
slaughtered the deer with a meat saw, skinned it, cut the deer meat into pieces and cleaned it 
up. They then cooked the deer meat and consumed it. Neither he nor his hunting partner had 
any food-poisoning symptoms after eating the meat. A few days after this hunting venture, 
the patient flew back to his family-home located about 1800 km from Tawau and was 
brought to the hospital by his family members as he was experiencing severe pain on his left 
thigh. According to our patient, his hunting partner also experienced fever and lower leg pain 
at about the same time as him. Unfortunately, we could not obtain any further history 
regarding his hunting partner as our patient lost contact with him once he left Tawau. 
Apart from deer, he was not exposed to any other animals including companion animals. He 
is a regular smoker; however he does not use intravenous drugs and had no history of 
acupuncture, trauma, recent travel abroad or involvement in recreational activities like river 
rafting, diving or contact sports. He is single and denies homosexual behavior. 
His vital signs on admission revealed a temperature of 38.7°C, heart rate of 90 beats/min and 
blood pressure of 120/78 mmHg. His left thigh was warm and tender with a deep ill-defined 
swelling measuring 20 cm by 8 cm. There were no discharging sinuses or other skin or soft 
tissue lesions noted. His left knee movement was restricted due to pain; however there was no 
swelling or tenderness of the knee joint. There was no inguinal lymphadenopathy and 
neurological and vascular testing was unremarkable. His lungs were clear both clinically and 
radiologically and examination of other systems was unremarkable. 
Plain anteroposterior radiography revealed an osteolytic lesion with erosion of cortex and 
periosteal reaction involving the mid-shaft of the left femur (Figure 1). A magnetic resonance 
imaging done (MRI) showed involvement of the mid-shaft of left femur with surrounding 
circumferential soft tissue involvement (Figure 2). The technetium-99m bone scan showed 
isolated uptake of the left mid and distal femur (Figure 3). A provisional diagnosis of 
osteosarcoma was made based on the radiological findings. 
Figure 1 Plain radiograph shows destruction of the posterior medial cortex of the mid-
shaft of left femur with periosteal reaction associated with a soft tissue shadow 
Figure 2 Shows MRI sagittal and axial views of the both the femurs. There are signal 
changes in the diaphyseal region of the left femur with circumferential soft tissue 
involvement 
Figure 3 Bone scan showing isolated uptake of the left mid and distal femur 
Initial blood investigations revealed leukocytosis (17.7 x 10
9
/L) with 86% neutrophils, 
normal haemoglobin and platelets. The C-reactive protein (CRP) and erythrocyte 
sedimentation rate (ESR) were both markedly elevated at 45.6 mg/dL and 140mm/hour 
respectively. All other blood investigations were normal. Blood cultures were taken on day of 
admission and we proceeded to a needle biopsy. Three days later, both blood and bone biopsy 
cultures grew MRSA. 
Patient was immediately commenced on intravenous vancomycin 1 gram bd, based on 
antibiotic sensitivity results. An incision and drainage was performed for the left thigh 
abscess and the cultures of pus also yielded MRSA. Management of the patient was 
complicated by a pathological fracture of the distal third of left femur sustained during an 
incision and drainage when a manipulation under anaesthesia was performed at the same time 
for the stiff knee (Figure 4). The fracture was managed with skin traction. Meanwhile, 
histopathological examination of the bone biopsy revealed acute on chronic suppurative 
inflammation with no evidence of granulomas or neoplastic cells. Ziehl- Neelsen stain did not 
reveal acid-fast bacilli and fungal stains were negative. A transthoracic echocardiogram done 
showed no evidence of valve vegetation, excluding the possibility of infective endocarditis. 
Ultrasound of abdomen did not reveal abscesses or other abnormalities. Placement of a 
peripherally inserted central catheter (PICC) line was done for long term antibiotics 
administration. Hepatitis B and HIV screening were performed and both were negative. 
Figure 4 Radiograph demonstrating pathological fracture of the distal third of the left 
femur with shortening 
One month after initiation of treatment, the patient finally showed some improvement. His 
leukocytes, ESR and CRP demonstrated a downward trend and were 10.2 x 10
9
/L, 125 
mm/hour and 9.1 mg/dL respectively (Table 1). At about the same time, the patient 
developed swelling and tenderness of his left knee and a knee arthrotomy and washout was 
performed, the knee aspirate too grew MRSA with similar antibiogram as the previous 
isolates. Subsequently, fusidic acid was added to vancomycin. Following this, the 
temperature started to settle. Vancomycin level monitoring was regularly done to evaluate 
drug toxicity and vancomycin was continued till discharge. 
Table 1 Acute phase reactants levels during the clinical course of disease 
Time from 
hospitalization 
On 
admission 
1 
week 
2 
week 
1 
month 
2
nd
 
month 
3 
month 
5 
month 
6 
month 
10 
month 
14 
month 
WBC x 10
9
/L 17.7 21.9 18.5 10.2 5.4 6.8 6.9 8.3 8.7 9.1 
ESR (mm/h) >140  >140 125 122 93 34 16 14 25 
C-reactive 
protein (mg/dl) 
45.6  19.8 9.1 7.5 2.6  1 1 0.8 
Patient was discharged on day 73 of admission with fusidic acid 500mg tds and rifampicin 
300 mg tds and was advised non-weight bearing. At 2 weeks post-discharge follow-up, the 
leukocyte counts, ESR and CRP were 6.8 x 10
9
/L, 93 mm/hour and 2.6 mg/dl respectively. It 
took 6 months for the ESR and CRP to normalize, indicating active inflammation; requiring 
6-months of anti-MRSA therapy. During the subsequent months, the left thigh pain had 
improved substantially and patient was able to ambulate. Patient was back to work and was 
able to perform his daily activities without limitations within one year. At 2-year follow-up, 
he had full function of his left lower limb and there was no evidence of relapse. 
Phenotypic and genotypic characterization of MRSA strain 
Antimicrobial susceptibility testing (Oxoid Ltd, Bastingstoke, UK) was performed and 
interpreted by the Clinical and Laboratory Standards Institute (CLSI) disc diffusion method. 
Characterization of SCCmec types and detection of pvl gene was performed using conditions 
as previously described [6]. Detection of 20 other virulent genes; sea, seb, sec, sed, see, seg, 
seh, sei, sej (enterotoxin genes); eta, etb, etd (exfoliative toxin genes), tst (toxic-shock 
syndrome toxin gene), efb (extracellular fibrinogen binding protein), fnbA, fnbB (fibronectin 
binding protein), cna (collagen-adhesin gene), hlg (γ-hemolysin genes), ica (intracellular-
adhesin gene) and sdr (putative-adhesin gene) was performed by multiplex PCR using GoTaq 
DNA Polymerase (Promega Madison Wis, USA) following conditions previously described 
[6-10]. Typing of staphylococcus protein A (spa), mec-associated dru and multilocus 
sequence type (MLST) was performed using established protocols as described by web-based 
electronic database (http://www.dru-typing.org/; http://saureus.mlst.net/misc/info.asp; 
http://www.ridom.de/doc/Ridom_spa_sequencing.pdf ), whereas typing of accessory gene 
regulator (agr) group was performed as previously described by Moore and Lindsay [10]. 
Results of phenotypic and genotypic characterization 
The isolate was sensitive to non-beta-lactam antibiotics including vancomycin, teicoplanin, 
rifampicin, fusidic acid, trimethoprim- sulfamethoxazole (TMP-SMX), tetracycline, 
ciprofloxacin, gentamicin, netilmicin and clindamycin but resistant to erythromycin. Based 
on the D-zone test, this isolate showed inducible-clindamycin resistance. Molecular 
characterization of this isolate showed that it belonged to MLST type ST30 and exhibited the 
SCCmec type IV, spa type t019, agr type III and dru type dt10m. This strain, tested positive 
for 4 virulence genes; pvl (cytotoxin) (Figure 5), sei (enterotoxin), fnbA (fibronectin binding 
protein) and hlg (γ-hemolysin). This strain lacked the exfoliative gene, toxic-shock syndrome 
toxin gene and the other virulent genes tested. 
Figure 5 Agarose gel electrophoresis demonstrating the results of PCR for PVL gene. 
Lane 1: 100 bp DNA marker; Lane 2 & 3: positive PVL gene control; Lane 4 & 5: patient’s 
sample carrying PVL gene; Lane 6: negative PVL gene control 
Discussion 
This previously healthy adult developed an invasive CA-MRSA infection manifesting as 
bacteraemia, osteomyelitis of femur, pyomyositis and septic arthritis. Osteomyelitis is a rare 
entity of CA-MRSA presentation, especially so amongst adults. A database search of 
MEDLINE and Scopus for all years, revealed only 8 cases of acute osteomyelitis caused by 
CA-MRSA in adults (≥ 18 years). The clinical features of the 9 cases (including the one 
described here) are shown in Table 2 [11-16]. Long bones were most commonly involved (6 
femur and 1 humerus). In 2 other patients the osteomyelitis involved the rib and lumbar spine 
respectively. Pyomyositis was an accompanying manifestation in 5 cases and septic arthritis 
in 2 patients. Amongst the 9 patients, there was concomitant bacteraemia in 6 patients. In a 
study involving Staphylococcus aureus bacteraemic adults in Taiwan, 16.7% (5/30) of CA-
MRSA bacteraemic patients and 20.5% (38/185) of CA-MSSA bacteraemic patients 
presented with osteomyelitis or septic arthritis [17]. The lack of underlying disease concurred 
with the experience at most areas where CA-MRSA is described [11-13,15]. Hepatitis C was 
the only underlying disease described, present in 3 out of 9 patients who also had a history of 
intravenous drug abuse. The probable source of infection was skin and soft tissue 
(furunculosis and cellulitis); noted in 6 out of the 9 patients. Risk factors that have been 
previously identified for CA-MRSA infection includes neonates, school children, university 
students, athletes, military personnel, cystic fibrosis patients, jail inmates, men who have sex 
with men (MSM), household contacts, urban undeserved communities, indigenous population 
and HIV patients [1,4]. MRSA is now increasingly recognized in the animal population and 
has emerged as possible reservoirs for human MRSA infection in the community, reported in 
diverse species of animals including domestic pets, livestock, wild birds and other animals 
[1]. Since no identifiable risk factors were present in our patient, we speculate that he 
acquired CA-MRSA through extensive direct contact with deer and also possibly through 
consumption of contaminated deer meat. Although there have not been reported cases of CA-
MRSA in deer, other antibiotic resistant bacteria e.g. resistant E.coli have been found in wild 
animals including deer that have not been directly exposed to antibiotics [18]. Our patient 
was infected with CA-MRSA ST30 which has been found to be associated with pigs [19]. 
Animals such as deer may constitute an unrecognized source of CA-MRSA infection in 
natural environment, and more research is needed to assess the importance of deer as 
reservoirs of MRSA. 
Table 2 Review of acute osteomyelitis cases caused by CA-MRSA in adults 
No Ref Age/ 
sex 
Underlying 
disease 
Probable source of entry Symptoms Manifestation Culture 
source 
PVL Treatment Outcome 
1 11* 27/M None History of furunculosis 
Contact with gym facilities 
Leg pain Fever Femur osteomyelitis Bone + Vancomycin −8 weeks Surgical 
debridement 
Recovered and no 
relapse during 
follow-up 
2 11 * 37/M Hepatitis C 
Hypertension 
History of furunculosis 
Contact with children with 
‘skin bumps’ 
Leg pain Fever Femur osteomyelitis Bone + Vancomycin- 8 weeks Surgical 
debridement 
Recovered and no 
relapse during 
follow-up 
IVDU 
3 12 45/M None NA Right hemithorax 
pain and swelling 
Fever 
First rib osteomyelitis, pyomyositis, thoracic 
wall abscesses, septicaemia 
Bone Blood 
Pus Tissue 
+ Clindamycin, tobramycin+ linezolide, 
vancomycin (given at different times for 
6 weeks) 
Recovered 
Surgical debridements Abscess drainage 
4 13 * 34/M None Axillary furuncle Thigh pain Femur osteomyelitis, bacteraemia Bone Blood NA Vancomycin +rifampicin Recovered and no 
relapse during 
follow-up 
– 12 weeks 
Surgical debridement Intramedullary rod 
5 14 * 46/F Hypertension History of furunculosis in 
patient and daughter 
Arm pain Humerus osteomyelitis with pathological 
fracture 
Bone NA Vancomycin+ rifampicin (various 
combination total of 16 weeks) 
Recovered and no 
relapse during 
follow-up Surgical debridement 
ORIF 
6 14 28/F Hepatitis C History of furunculosis 
Subcutaneous heroin 
injection 
Thigh pain and 
swelling 
Femur osteomyelitis Pyomyositis, bacteraemia Bone Blood NA Vancomycin, linezolide, daptomycin 
(various combination) 
Recovered and no 
relapse during 
follow-up ORIF 
Surgical debridement 
7 15 22/M None Elbow cellulitis Works at 
military base 
Knee and thigh pain 
Fever 
Femur osteomyelitis. septic arthritis of knee 
bacteraemia, thigh abscess, endocarditis, septic 
lung emboli, deep vein thrombosis 
Wound 
Blood 
+ Vancomycin + clindamycin, Survived with 
disabilities Vancomycin + linezolid (various 
combination- total of 8 weeks) 
Incision and drainage 
8 16 46/M Hepatitis C with 
cirrhosis 
IVDU Back pain Fever Lumbar osteomyelitis, pyomyositis of 
paraspinal and psoas muscle, spinal epidural 
abscess, bacteraemia 
Blood Pus NA Abscess drainage Recovered and no 
relapse during 
follow-up 
Surgical debridement Vancomycin- 6 
weeks 
9 Present* 
Case 
28/M None Extensive direct contact 
with deer 
Thigh pain and 
swelling Fever 
Femur osteomyelitis, septic arthritis of knee 
pyomyositis bacteraemia 
Bone Blood 
Pus Tissue 
+ Abscess drainage Arthrotomy Recovered and no 
relapse during 
follow-up 
Surgical debridement 
Vancomycin+fusidic Fusidic + 
rifampicin- 6 months Consumed deer meet 
*Suspected primary bone malignancy 
NA- not available 
One noteworthy finding is that CA-MRSA osteomyelitis involving the long bones has a 
propensity to mimic malignant bone tumors radiologically (5 out of the 7 long bone 
osteomyelitis in our review). Symptoms such as fever, bone pain, loss of weight, loss of 
appetite are non-specific and may not differentiate osteomyelitis or bone tumors. Pain of 
moderate to severe intensity was a constant feature in all patients (Table 2) and may suggest 
the diagnosis of osteomyelitis. Our patient was initially suspected to have osteosarcoma 
based on radiological findings, which was ruled out by a needle biopsy. Biopsy also 
identified the causative pathogen so that appropriate antibiotic treatment could be 
administered. Vancomycin is the first-line intravenous drug for severe CA-MRSA infections 
[1]. Oral agents recommended for treatment of CA-MRSA infections include clindamycin, 
doxycycline, co-trimoxazole, rifampicin and fusidic acid [2]. Rifampicin or fusidic acid 
should not be used as monotherapy because of the possible emergence of resistance [2]. 
Clindamycin should be used with caution since erythromycin resistant isolates can have 
inducible resistance to clindamycin [1]. This was the case in our patient as determined by the 
D-zone test. 
Our patient had an uneventful recovery with no evidence of relapse at 2 year follow-up. 
Peyrani et al. [20] conducted a study involving 50 patients with MRSA osteomyelitis of 
which 54% were due to MRSA USA-300 (mainly CA-MRSA, SCCmec type IV). Although 
the rate of treatment failure was similar for patients with MRSA USA-300 osteomyelitis 
versus patients with MRSA non–USA-300 (mainly healthcare-associated, SCCmec type III), 
patients with more severe initial clinical presentation were most likely infected with MRSA 
USA-300 strains. In another study comparing CA-MRSA and CA-MSSA osteomyelitis, there 
was no difference in the final outcome of patients from these 2 groups, although the subset of 
CA-MRSA osteomyelitis patients were more likely to have complications such as chronic 
osteomyelitis and deep vein thrombosis [21]. 
Testing for pvl gene was done on 5 patients and all 5 tested positive (Table 2). PVL is a 
cytotoxin responsible for the destruction of leucocytes and is encoded by pvl genes namely 
lukS-PV and lukF-PV [2] and plays an important role in the pathogenesis of severe invasive 
infections such as skin and soft tissue infections, osteomyelitis and necrotizing pneumonia, 
contributing to tissue necrosis and abscess formation. In a study involving acute 
hematogenous S. aureus osteomyelitis in children, pvl positive isolates had significantly 
higher ESR and CRP at presentation and were more likely to have a blood culture positive 
and contiguous pyomyositis or myositis [5]; concluding that pvl gene is strongly associated 
with the severity of acute osteomyelitis. Our patient had very high inflammatory markers at 
presentation. With appropriate treatment, these markers gradually demonstrated a downward 
trend. It took 6 months for these markers to almost normalize, necessitating 6 months of anti-
MRSA treatment. Early and prolonged administration of anti-MRSA treatment until all 
inflammatory parameters normalized contributed to a favorable outcome of our patient. The 
CA-MRSA isolated from our patient was pvl positive, ST30/spa19 which have been found to 
be highly virulent and shown to be associated with life-threatening invasive infections, 
including pelvic abscesses, osteomyelitis and pneumonia in children and adolescent athletes 
[22]. 
The MRSA strain of our patient was also tested positive for sei, fnbA and hlg . Fibronectin-
binding proteins (FnBPA and FnBPB) encoded by fbpA and fbpB genes play a role in 
enhanced bacterial adherence to fibronectin and invasion of host cells including epithelial 
cells and fibroblasts and were significantly more frequently detected in S. aureus invasive 
strains (responsible for osteomyelitis, septic arthritis and endocarditis) compared with nasal 
carriage isolates [5,8]. γ- hemolysin are cytolysins also with both leukocidin and hemolysin 
properties [4]. In addition to being classified as members of the pyrogenic toxin superantigen 
family, Staphylococcal enterotoxins (SEs) are emetic toxins and se genes are frequently 
detected in isolates that originated from food poisoning outbreaks. Although the sei gene was 
detected, our patient did not have manifestations of food-poisoning as the sei- harboring 
isolate may not have produced enough SEI enterotoxins to cause food poisoning [9]. 
Conclusion 
This case highlights the importance of a high index of suspicion for early diagnosis of CA-
MRSA, especially in the context of an immunocompetent adult. Clinicians need to be 
attentive that beyond the most commonly encountered skin and soft tissue infections, pvl 
positive CA-MRSA can lead to invasive life-threatening disease. Heightened vigilance is 
needed for CA-MRSA osteomyelitis of long bones in adults as it is not uncommon for this 
disease to mimic primary bone malignancy, which can be ruled out based on bone biopsy 
supported by microbiological evidence. Cure is achievable with early appropriate antibiotics 
guided by inflammatory markers. 
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Figure 5: Agarose gel electrophoresis demonstrating the results of PCR for PVL gene  
Lane 1: 100 bp DNA marker; Lane 2 & 3: positive PVL gene control; Ncpg"6"("7<"rcvkgpvÓs 
sample carrying PVL gene; Lane 6: negative PVL gene control 
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